Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson's Disease.

Neuromolecular medicine - 1 Jun 2021

Jin Tao, Tan Xuling, Shi Xiaoliu, Lv Lingling, Peng Xinke, Zhang Hainan, Tang Beisha, Wang Chunyu, Yang Mei

Abstract excerpt

The nuclear envelope component proline-rich protein 14 (PRR14) is involved in the nuclear morphological alteration and activation of the mTOR (mammalian target of rapamycin) signaling pathway, and has been repeatedly shown to be upregulated in patients with Parkinson's disease (PD). The aim of this study was to explore whether PRR14 can be used as a potential biomarker for the diagnosis of PD. We compared PRR14...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to TOR Serine-Threonine Kinases
Share to Chromosomal Proteins, Non-Histone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Constipation

Share to Plasma

Share to ROC Curve

Share to Substantia Nigra

Share to Symptom Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 33001354
DOI: 10.1007/s12017-020-08617-z
PMCID: PMC8128746

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson's Disease.PMID 33001354Read ↗

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsSemantic proximity Read ↗

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteinsSemantic proximity Read ↗

Identification of proteins in human substantia nigra.Semantic proximity Read ↗

Neutrophil percentage-to-albumin ratio increases the risk of Parkinson’s disease and all-cause mortality in Parkinson’s disease patients: A population-based StudySemantic proximity Read ↗

Integrative Transcriptomic and Systems-Level Analysis Identifies GPCR- Related Biomarkers NTSR1 and GPR161 in Parkinson’s DiseaseSemantic proximity Read ↗

Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell lineSemantic proximity Read ↗

Pael receptor is involved in dopamine metabolism in the nigrostriatal system.Semantic proximity Read ↗

The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain.Semantic proximity Read ↗

Parkinson’s Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAsSemantic proximity Read ↗

Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjectsSemantic proximity Read ↗

SEPT14 Is Associated with a Reduced Risk for Parkinson's Disease and Expressed in Human Brain.Semantic proximity Read ↗

miR-185 and SEPT5 Genes May Contribute to Parkinson’s Disease PathophysiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.